Back
Viking Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
VKTX
Viking Therapeutics
Last Price:
52.65
Seasonality Move:
50.47%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Viking Therapeutics Price Quote
$52.65
+1.12 (+2.17%)
(Updated: November 21, 2024 at 11:35 AM ET)
Viking Therapeutics Key Stats
Sell
37
Viking Therapeutics (VKTX)
is a Sell
Day range:
$50.40 - $53.04
52-week range:
$11.21 - $99.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6%
Volume:
3.5M
Avg. volume:
5.5M
1-year change:
337.81%
Market cap:
$5.5B
Revenue:
$0
EPS:
$-0.93
How Much Does Viking Therapeutics Make?
Data Unavailable
Is Viking Therapeutics Growing As A Company?
Data Unavailable
Viking Therapeutics Stock Price Performance
-
Did Viking Therapeutics Stock Go Up Last Month?
Viking Therapeutics share price went down by -21.69% last month -
Did VKTX's Share Price Rise Over The Last Year?
VKTX share price rose by 337.81% over the past 1 year
What Is Viking Therapeutics 52-Week High & Low?
-
What Is Viking Therapeutics’s 52-Week High Share Price?
Viking Therapeutics has traded as high as $99.41 over the past 52 weeks -
What Is Viking Therapeutics’s 52-Week Low Share Price?
Viking Therapeutics has traded as low as $11.21 over the past 52 weeks
Viking Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Viking Therapeutics?
-
How Much Debt Does Viking Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Viking Therapeutics Have?
Cash and short term investments quarterly total is $930.4M -
What Is Viking Therapeutics’s Book Value Per Share?
Book value per share is 8.18
Is Viking Therapeutics Cash Flow Positive?
-
What Is VKTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$74.2M -
What Is Viking Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $611.7M -
What Is Viking Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$524.2M
Viking Therapeutics Return On Invested Capital
Data Unavailable
Viking Therapeutics Earnings Date & Stock Price
-
What Is Viking Therapeutics's Stock Price Today?
A single share of VKTX can be purchased today for 51.53 -
What Is Viking Therapeutics’s Stock Symbol?
Viking Therapeutics trades on the nasdaq under the ticker symbol: VKTX -
When Is Viking Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Viking Therapeutics is scheduled on February 7, 2025 -
When Is VKTX's next ex-dividend date?
Viking Therapeutics's next ex-dividend date is November 21, 2024 -
How To Buy Viking Therapeutics Stock?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Viking Therapeutics Competitors
-
Who Are Viking Therapeutics's Competitors?
Below is a list of companies who compete with Viking Therapeutics or are related in some way:
Viking Therapeutics Dividend Yield
-
What Is VKTX Dividend Yield?
Viking Therapeutics’s dividend yield currently is 0% -
What Is Viking Therapeutics’s Payout Ratio?
Viking Therapeutics’s payout ratio is 0% -
When Did Viking Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Viking Therapeutics’s Dividend Per Share?
Viking Therapeutics pays a dividend of $0.00 per share
Viking Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 8.12% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 112.85 |
| Upside from Last Price: | 118.99% |